Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) — Form 8-K: Current report
About this filing
Bolt Biotherapeutics, Inc. (BOLT) filed an 8-K on Nov 12, 2026 reporting results of operations (earnings) (Item 2.02), with exhibits (Item 9.01).
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More BOLT filings
- SC 13G/A
Filed Nov 12, 2026
- 4
Filed Nov 10, 2026
- 3
Filed Nov 6, 2026
- SC 13G
Filed Nov 6, 2026
- 4
Filed Oct 27, 2026
- 3
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.